X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (546) 546
Patent (69) 69
Book Chapter (7) 7
Government Document (3) 3
Publication (2) 2
Book / eBook (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (291) 291
female (255) 255
oncology (240) 240
breast cancer (216) 216
breast neoplasms - drug therapy (143) 143
breast neoplasms - genetics (140) 140
middle aged (136) 136
breast neoplasms - pathology (131) 131
chemotherapy (125) 125
cancer (119) 119
adult (102) 102
aged (102) 102
prognosis (99) 99
gene expression (71) 71
gene expression profiling (71) 71
research (68) 68
antineoplastic combined chemotherapy protocols - therapeutic use (63) 63
breast neoplasms - metabolism (60) 60
neoadjuvant therapy (59) 59
survival (57) 57
treatment outcome (56) 56
gene expression regulation, neoplastic (52) 52
tumors (51) 51
neoplasm staging (50) 50
chemistry (47) 47
chemotherapy, adjuvant (47) 47
care and treatment (45) 45
metallurgy (45) 45
preoperative chemotherapy (45) 45
therapy (45) 45
biochemistry (44) 44
physics (44) 44
genetic aspects (43) 43
antineoplastic agents - therapeutic use (42) 42
doxorubicin (41) 41
beer (40) 40
compositions or test papers therefor (40) 40
condition-responsive control in microbiological orenzymological processes (40) 40
enzymology (40) 40
measuring or testing processes involving enzymes, nucleicacids or microorganisms (40) 40
microbiology (40) 40
mutation or genetic engineering (40) 40
processes of preparing such compositions (40) 40
receptors, estrogen - metabolism (40) 40
spirits (40) 40
vinegar (40) 40
wine (40) 40
medicine & public health (39) 39
neoadjuvant chemotherapy (39) 39
trastuzumab (38) 38
predictive value of tests (37) 37
cyclophosphamide (36) 36
biomarkers (35) 35
receptor, erbb-2 - metabolism (35) 35
testing (35) 35
aged, 80 and over (34) 34
breast neoplasms - diagnosis (34) 34
breast neoplasms - mortality (34) 34
genes (34) 34
breast neoplasms - therapy (33) 33
investigating or analysing materials by determining theirchemical or physical properties (33) 33
measuring (33) 33
oligonucleotide array sequence analysis (33) 33
women (33) 33
paclitaxel (32) 32
estrogen (30) 30
expression (30) 30
gene-expression profiles (30) 30
breast neoplasms - surgery (29) 29
metastasis (29) 29
mutation (29) 29
paclitaxel - administration & dosage (29) 29
disease-free survival (28) 28
pathological complete response (28) 28
sensitivity (28) 28
analysis (27) 27
clinical trials (27) 27
diagnosis (26) 26
health aspects (26) 26
immunohistochemistry (26) 26
adjuvant treatment (25) 25
biomarkers, tumor - genetics (25) 25
genomics (24) 24
research article (23) 23
biomarkers, tumor - analysis (22) 22
biomarkers, tumor - metabolism (22) 22
cells (22) 22
docetaxel (22) 22
gene-expression (22) 22
survival analysis (22) 22
tamoxifen (22) 22
abridged index medicus (21) 21
carcinoma (21) 21
drug therapy (21) 21
patients (21) 21
risk factors (21) 21
markers (20) 20
reproducibility of results (20) 20
risk (20) 20
usage (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 8, pp. 790 - 800
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9805, pp. 1812 - 1823
Summary Microarray-based gene expression profiling has had a major effect on our understanding of breast cancer. Breast cancer is now perceived as a... 
Internal Medicine | Breast Neoplasms - classification | Receptors, Progesterone - analysis | Breast Neoplasms - genetics | Prognosis | Humans | Female | Gene Expression Profiling | Receptors, Estrogen - analysis | Receptor, ErbB-2 - analysis | Care and treatment | Breast cancer | Diagnosis | Research | Gene expression
Journal Article
Cancer, ISSN 0008-543X, 04/2011, Volume 117, Issue 8, pp. 1575 - 1582
Breast cancer is a heterogeneous disease of different subtypes on the molecular, histopathological, and clinical level. Genomic profiling techniques have led... 
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9816, pp. 633 - 640
Summary Background The anti-HER2 monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib have complementary mechanisms of action and... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | APOPTOSIS | WOMEN | MEDICINE, GENERAL & INTERNAL | GW572016 | SAFETY | ERBB2 | INHIBITOR | COMBINATION | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Diarrhea - chemically induced | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Liver - drug effects | Adult | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Lapatinib | Biomarkers, Tumor - antagonists & inhibitors | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Liver - metabolism | Paclitaxel - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Drug therapy | Breast cancer | Genetic aspects | Ultrasonic imaging | Surgery | Diarrhea | Cytotoxicity | Ligands | Cancer therapies | Tumors | Medical research | Mammography | Kinases | pathology | Liver | methods | Antibodies | Oral | Quinazolines | Breast Neoplasms | Tumor Markers | administration & dosage | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Monoclonal | chemistry | Administration | drug therapy | chemically induced | Intravenous | Infusions | Humanized | Antineoplastic Combined Chemotherapy Protocols | drug effects | Biological | analysis | Kirurgi | antagonists & inhibitors | Chemotherapy | Receptor | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
Nature biotechnology, ISSN 1546-1696, 2013, Volume 31, Issue 11, pp. 1023 - 1031
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2008, Volume 26, Issue 8, pp. 1275 - 1281
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 1, pp. 23 - 34
Journal Article
Annals of surgical oncology, ISSN 1534-4681, 2011, Volume 19, Issue 5, pp. 1508 - 1516
Journal Article